Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

NCT00295061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG: Alpha-1 MP
DRUG: alpha-1 proteinase inhibitor (human)

Sponsor

Grifols Therapeutics LLC